•
Archive: https://archive.today/AMTmH
From the post:
>Moderna is set to slash ten percent of its workforce this year, the pharmaceutical giant revealed on Thursday morning. The company - the maker of one of the most prevalent Covid-19 vaccines - now faces uncertainty as that market dwindles. The move, announced in an internal memo by CEO Stephane Bancel, is part of the company's previous plan to cut operating expenses by about $1.5 billion by 2027. 'We've made significant progress by scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs,' Bancel said in the memo.
Archive: https://archive.today/AMTmH
From the post:
>>Moderna is set to slash ten percent of its workforce this year, the pharmaceutical giant revealed on Thursday morning.
The company - the maker of one of the most prevalent Covid-19 vaccines - now faces uncertainty as that market dwindles.
The move, announced in an internal memo by CEO Stephane Bancel, is part of the company's previous plan to cut operating expenses by about $1.5 billion by 2027.
'We've made significant progress by scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs,' Bancel said in the memo.
(post is archived)